EXAS vs SURG · rev $2.76B vs rev $16.2M
EXACT Sciences Corporation (EXAS) versus Surgepays Inc (SURG) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Surgepays Inc (SURG) is a telecom services company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported SURG revenue for 2026-06-30 was $16.2M. Net income was $1.3M. Revenue was up 1.4% from 2026-03-31 to 2026-06-30. SURG currently screens at market cap $11.8M.
EXAS currently screens at market cap $20.03B. SURG currently screens at market cap $11.8M.
Not investment advice. Open the EXAS and SURG stock pages for the full models.
Not investment advice.